ArticleJournal of translational medicine2024

CircRHBDD1 promotes immune escape via IGF2BP2/PD-L1 signaling and acts as a nanotherapeutic target in gastric cancer.

Yanna Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.